The 2026 Nobel Prize in Medicine has highlighted one of the most transformative breakthroughs in modern neuroscience: optogenetics.

This technology allows scientists to activate or silence neurons using light with unprecedented precision, opening new possibilities to understand the human brain and develop future therapies for neurological diseases.

But behind this breakthrough lies something many people would never expect to find at the center of medical innovation: a microalga.

The key protein that made this technology possible, known as channelrhodopsin-2 (ChR2), was discovered in Chlamydomonas, a light-sensitive green microalga.

What exactly is optogenetics?

Optogenetics combines biology, genetics and light to control nerve cells.

Researchers discovered that certain proteins found in photosensitive organisms can work as biological “light switches.”

When the ChR2 protein is introduced into neurons, these cells can be activated using highly precise light pulses.

For the first time, scientists were able to control specific neurons in real time.

The consequences were revolutionary: researchers can now study how neural circuits related to memory, emotions, behavior, vision and neurodegenerative diseases actually function.

The connection between microalgae and neuroscience

Chlamydomonas uses light to orient itself in its environment through a light-sensitive structure called an eyespot.

Scientists discovered that this capability depended on proteins able to generate rapid electrical signals when exposed to light.

That discovery completely changed modern neuroscience.

What originally evolved as a biological mechanism in a microalga ultimately became a tool capable of controlling human neurons using light.

It is a remarkable example of how microscopic organisms can become biotechnology platforms with real medical applications.

Medical applications already shaping the future

Today, optogenetics is already being used in advanced research to:

  • study neural circuits involved in memory and learning,
  • investigate diseases such as Alzheimer’s, Parkinson’s and depression,
  • develop new vision restoration strategies,
  • improve neural interfaces and auditory implants,
  • better understand interactions between the brain, emotions and organs.

Although many applications are still under development, the impact of this technology is already transforming medicine and neuroscience.

The potential of microalgae goes far beyond sustainability

This Nobel Prize also highlights something important for modern biotechnology: microalgae are not only relevant for nutrition, sustainability or agriculture.

They can also become a source of advanced biomolecular tools capable of driving the next generation of medical and technological innovation.

At Neoalgae, we continue believing in the enormous potential of microalgae as a platform for solutions with real impact across industries.

Science continues to demonstrate that some of the most important breakthroughs of the future may begin with microscopic organisms.